| 000 | 01400 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250515223345.0 | ||
| 264 | 0 | _c20101001 | |
| 008 | 201010s 0 0 eng d | ||
| 022 | _a1866-0452 | ||
| 024 | 7 |
_a10.3238/arztebl.2010.0279 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSchott, Gisela | |
| 245 | 0 | 0 |
_aThe financing of drug trials by pharmaceutical companies and its consequences. Part 1: a qualitative, systematic review of the literature on possible influences on the findings, protocols, and quality of drug trials. _h[electronic resource] |
| 260 |
_bDeutsches Arzteblatt international _cApr 2010 |
||
| 300 |
_a279-85 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Systematic Review | ||
| 650 | 0 | 4 |
_aClinical Trials as Topic _xeconomics |
| 650 | 0 | 4 |
_aConflict of Interest _xeconomics |
| 650 | 0 | 4 |
_aDrug Industry _xeconomics |
| 650 | 0 | 4 | _aEthics, Pharmacy |
| 650 | 0 | 4 | _aGermany |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aPublication Bias |
| 650 | 0 | 4 |
_aResearch Support as Topic _xeconomics |
| 700 | 1 | _aPachl, Henry | |
| 700 | 1 | _aLimbach, Ulrich | |
| 700 | 1 | _aGundert-Remy, Ursula | |
| 700 | 1 | _aLudwig, Wolf-Dieter | |
| 700 | 1 | _aLieb, Klaus | |
| 773 | 0 |
_tDeutsches Arzteblatt international _gvol. 107 _gno. 16 _gp. 279-85 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3238/arztebl.2010.0279 _zAvailable from publisher's website |
| 999 |
_c19822092 _d19822092 |
||